Stay updated with breaking news from Arc Module. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The firm said the new workflow eliminates the need to batch multiple specimen tests, cutting hours off the wait for microbial ID results for positive blood cultures.
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) an in-vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis, today announced the release of new data on the Accelerate Arc Module and BC kit at the 32nd European Congress for Clinical Microbiology and ...
/PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) an in-vitro diagnostics company dedicated to providing solutions for the global challenges of...
New data shows the Accelerate Arc System enables automated and rapid sample preparation that yields robust reportability and accurate microbial id...